Analysis of Prognostic Factors for Overall Survival in PCL Patients
| Variable . | No. of Patients . | Median Survival (d) . | Univariate P . | Multivariate P . |
|---|---|---|---|---|
| β2-Microglobulin | ||||
| <6 mg/L | 8 | 560 | .0252 | .0037 |
| ≥6 mg/L | 15 | 138 | ||
| S-phase plasma cells | ||||
| <4.5% | 12 | 266 | .0459 | .0200 |
| ≥4.5% | 9 | 184 | ||
| ECOG scale | ||||
| <2 | 11 | 1,157 | .0014 | NS |
| ≥2 | 15 | 138 | ||
| Protein C reactivity | ||||
| <6 mg/dL | 7 | 1,157 | .0051 | NS |
| ≥6 mg/dL | 11 | 62 | ||
| Platelets | ||||
| <100 × 109/L | 12 | 116 | .0014 | NS |
| ≤100 × 109/L | 13 | 560 | ||
| Therapy | ||||
| Polychemotherapy | 14 | 560 | .0137 | NS |
| MP | 12 | 116 |
| Variable . | No. of Patients . | Median Survival (d) . | Univariate P . | Multivariate P . |
|---|---|---|---|---|
| β2-Microglobulin | ||||
| <6 mg/L | 8 | 560 | .0252 | .0037 |
| ≥6 mg/L | 15 | 138 | ||
| S-phase plasma cells | ||||
| <4.5% | 12 | 266 | .0459 | .0200 |
| ≥4.5% | 9 | 184 | ||
| ECOG scale | ||||
| <2 | 11 | 1,157 | .0014 | NS |
| ≥2 | 15 | 138 | ||
| Protein C reactivity | ||||
| <6 mg/dL | 7 | 1,157 | .0051 | NS |
| ≥6 mg/dL | 11 | 62 | ||
| Platelets | ||||
| <100 × 109/L | 12 | 116 | .0014 | NS |
| ≤100 × 109/L | 13 | 560 | ||
| Therapy | ||||
| Polychemotherapy | 14 | 560 | .0137 | NS |
| MP | 12 | 116 |